Podcast appearances and mentions of Kenneth L Davis

Derry Cooke is a Hypnotherapist, IAPCH member, and the Owner of HypnosisWorks, a hypnosis practice based in Whangarei, New Zealand where he specializes in helping people who have experienced trauma. By working with people through their trauma, he has committed himself to learning and internalizing other people’s methods and, over time, making them his own. Derry has a background in nursing with 30 years of experience in the health industry, gaining a reputation as the one who is good with difficult patients. He holds a bachelor’s degree in psychology from the University of Auckland. However, since discovering hypnosis at the age of nine, hypnotherapy and NLP have become Derry’s true passion. Check out the new on-demand hypnosis workshop: “Six Steps to a Six-Figure Hypnosis Business.” Yours free, right now at http://JasonWebinar.com/ Derry joins me today to discuss remodelling hypnosis. He shares how we can better approach the process of change by having better perspectives. He explores updating the models in terms of the classic NLP presuppositions and asks whether hypnotists have all the resources we need to create change. We discuss faith and how it applies to hypnosis. Derry breaks down The Arrow Technique and the interactions between negative and positive emotions. He also shares why it is vital to create consistency in our change work so we can ask the right questions at the right time to serve our clients better.   “When you take this fresh approach to looking at things, your efficacy just goes up.” - Derry Cooke   How working on the body and deep tissue tension can elicit powerful memories, demonstrating the body and mind are one Derry’s experience with training with Freddy Jacquin and The Arrow Technique How The Arrow Technique can be used to ‘switch off’ chronic and acute pain The three emotions and primary energy behind issues that trouble people Using the positive drivers of human experience in The Arrow Technique The principles of Derry’s remodelling approach, why you should always test your work, and the significant benefits of understanding how your techniques work Resources Mentioned: http://worksmarthypnosis.com/324/ http://jasonwebinar.com/ Self Hypnotism: The Technique and Its Use in Daily Living by Leslie LeCron The Arrow Technique Session #190 – Freddy Jacquin on Hypnotherapy Keeping the Brain in Mind by Melissa Tiers Hypnosis Weekly podcast with Adam Eason Book: Affective Neuroscience: The Foundations of Human and Animal Emotions (Series in Affective Science by Jaak Panksepp Book: The Archeology of Mind: Neuroevolutionary Origins of Human Emotions (Norton Series on Interpersonal Neurobiology) by Jaak Pankseep and Lucy Biven Book: The Emotional Foundations of Neurobiological and Evolutionary Approach by Kenneth L. Davis, Jaak Pankseep, and Mark Solms Connect with Derry Cooke: HypnosisWorks HypnosisWorks on Facebook Derry Cooke on LinkedIn http://derrycooke.com http://remodellinghypnosis.com Join our next online certification course… wherever you are in the world! https://WorkSmartHypnosisLIVE.com/ Get an all-access pass to Jason’s digital library to help you grow your hypnosis business: https://www.hypnoticbusinesssystems.com/ Get instant access to Jason Linett’s entire hypnotherapeutic training library: https://www.hypnoticworkers.com/ If you enjoyed today’s episode, please send us your valuable feedback! https://www.worksmarthypnosis.com/itunes https://www.facebook.com/worksmarthypnosis/ Join the new WORK SMART HYPNOSIS COMMUNITY on Facebook! https://www.facebook.com/groups/worksmarthypnosis/ Want to work with Jason? Check out: https://www.virginiahypnosis.com/call/

Antibodies, convalescent plasma, gene-based vaccines — you may have heard these terms on the evening news, but what do they mean? How might they help in the battle against Covid-19? As the race to develop a vaccine continues, questions remain about effectiveness, testing, and whether people will actually get the vaccine once it’s on the market. Two medical experts involved in the fight explain the science behind developing effective protection. Judith Aberg is Chief of the Division of Infectious Diseases for Mount Sinai Health System. She’s leading Mount Sinai’s Covid-19 treatment guidelines and the hospital’s clinical trials unit. Florian Krammer is a professor of vaccinology at the Icahn School of Medicine at Mount Sinai. Kenneth L. Davis, president and CEO of Mount Sinai Health System, leads the conversation. Davis is a trustee of the Aspen Institute.As a 501(c)(3) nonprofit organization, the Aspen Institute is nonpartisan and does not endorse, support, or oppose political candidates or parties. Further, the views and opinions of our guests and speakers do not necessarily reflect those of the Aspen Institute.

Despite the shift in attitudes regarding marijuana that have taken place in response to continued legalization, health professionals are reminding us that this does not change the fact that the drug is not safe for high school and college students. Kenneth L. Davis of the Mount Sinai Health System and Mary Kreek from the Laboratory of the Biology of Addictive Diseases are sounding the warning that marijuana has a deleterious impact on cognitive development in adolescents. In fact, marijuana can impair executive function, processing speed, memory, attention span, and concentration. They say that the explanation is rather clear: the adolescent brain, especially its frontal cortex, is especially vulnerable. Simply stated, marijuana damages young brains. It’s important that we exercise our parental responsibility to nurture our children into a substance-free lifestyle. God calls us to care for our bodies that they may be used to serve and bring glory to Him.

The interview discusses: How Dr. Davis led one of the greatest financial turnarounds in medical history. The reasons why healthcare keeps becoming more expensive along with solutions on how to decrease costs without sacrificing care. Why drug pricing should be a trade issue. Why the current patent system discourages pharmaceutical innovation. What “value based” medicine is and why insurance companies and hospitals should consider adopting it. Why the National Institutes of Health is so vital to drug discovery. His thoughts on CVS's strategy of becoming an integrated health care provider. What serious healthcare problem he sees getting worse which he believes has the potential to bankrupt the entire Medicare system. And much more….Biography: Kenneth L. Davis, MD, President and Chief Executive Officer of the Mount Sinai Health System, is widely recognized as a visionary leader who has guided the institution on a strong and dramatic growth trajectory. In 2013, the Mount Sinai Health System was formed by the combination of The Mount Sinai Medical Center and Continuum Health Partners, becoming one of the largest nonprofit systems in the country with $8 billion in revenue, 42,000 employees, eight hospitals, and more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida. Prior to becoming CEO, Dr. Davis spent 15 years as Chair of Mount Sinai's Department of Psychiatry. He was the first Director for many of the institution's research entities, including Mount Sinai's National Institutes of Health (NIH)-funded Alzheimer's Disease Research Center, the Schizophrenia Biological Research Center at the Bronx Veterans Affairs Medical Center, the Silvio Conte Neuroscience Center to study schizophrenia, and the Seaver Autism Center for Research and Treatment. Additionally, he received one of the first and largest program project grants for Alzheimer's disease research from the NIH.

How do we bend the cost curve and provide top health care at the same time? Speakers: Kenneth L. Davis, Peter R. Orszag, Robert Rubin, Kevin Vigilante

Advances in genomics, personalized medicine, and new therapeutics frame part of the picture. So do changes in health care delivery, stemming from the Affordable Care Act (Obamacare), health care exchanges, and the effects of diminishing fees for service. Will we really add value at the same time as we diminish cost? Can we expect to defeat cancer? What will increasing longevity actually mean for health? Will we look to replacement organs grown from stem cells? Speakers: Richard Besser, Kenneth L. Davis